Top Markets
#1 0G 0G +11.60%
#2 Siacoin Siacoin +9.25%
#3 Cash Cat Cash Cat +8.48%
#4 Arbitrum Arbitrum +7.02%
#5 MarsCoin MarsCoin +6.90%
#6 Asteroid Shiba Asteroid Shiba +6.90%
#7 Seeker Seeker +6.12%
#8 Metis Metis +6.04%
#9 Useless Coin Useless Coin +5.01%
#10 Optimism Optimism +4.77%
Coin of the day
0G 0G
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Rang in aandelen #14209
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Aandeelprijs
$12.33
Laatst gesynchroniseerd: 2026-08-31
Marktkapitalisatie
$428.31M
Verandering (1 dag)
0.49%
Verandering (1 jaar)
39.01%
Land
US
Handel Fennec Pharmaceuticals Inc. (FENC)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Fennec Pharmaceuticals Inc. (FENC)
Het dividendrendement (TTM) van Fennec Pharmaceuticals Inc. (aandelsymbool: FENC) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Fennec Pharmaceuticals Inc. (FENC) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH